nodes	percent_of_prediction	percent_of_DWPC	metapath
Methoxsalen—CYP1A1—chronic obstructive pulmonary disease	0.237	0.509	CbGaD
Methoxsalen—CYP1A2—chronic obstructive pulmonary disease	0.229	0.491	CbGaD
Methoxsalen—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0863	0.224	CbGbCtD
Methoxsalen—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0863	0.224	CbGbCtD
Methoxsalen—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0654	0.17	CbGbCtD
Methoxsalen—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0384	0.0996	CbGbCtD
Methoxsalen—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.028	0.0727	CbGbCtD
Methoxsalen—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0228	0.0591	CbGbCtD
Methoxsalen—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0154	0.0399	CbGbCtD
Methoxsalen—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0147	0.0381	CbGbCtD
Methoxsalen—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0131	0.034	CbGbCtD
Methoxsalen—CYP2A13—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.0118	0.167	CbGpPWpGaD
Methoxsalen—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00768	0.0199	CbGbCtD
Methoxsalen—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00725	0.0188	CbGbCtD
Methoxsalen—CYP2A13—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00491	0.0692	CbGpPWpGaD
Methoxsalen—CYP2A13—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00376	0.053	CbGpPWpGaD
Methoxsalen—CYP2A13—respiratory system—chronic obstructive pulmonary disease	0.00274	0.449	CbGeAlD
Methoxsalen—CYP2A13—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.00221	0.0311	CbGpPWpGaD
Methoxsalen—CYP2A13—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00212	0.0299	CbGpPWpGaD
Methoxsalen—CYP1A1—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00193	0.0272	CbGpPWpGaD
Methoxsalen—CYP2A13—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.00154	0.0217	CbGpPWpGaD
Methoxsalen—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00151	0.0212	CbGpPWpGaD
Methoxsalen—CYP2A13—lung—chronic obstructive pulmonary disease	0.00146	0.239	CbGeAlD
Methoxsalen—Acneiform eruption—Prednisone—chronic obstructive pulmonary disease	0.00139	0.0193	CcSEcCtD
Methoxsalen—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00131	0.0185	CbGpPWpGaD
Methoxsalen—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00116	0.0164	CbGpPWpGaD
Methoxsalen—Leukoderma—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.0158	CcSEcCtD
Methoxsalen—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.0155	CcSEcCtD
Methoxsalen—CYP2A13—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.0153	CbGpPWpGaD
Methoxsalen—Dermatitis acneiform—Prednisone—chronic obstructive pulmonary disease	0.00103	0.0142	CcSEcCtD
Methoxsalen—Depression—Roflumilast—chronic obstructive pulmonary disease	0.000979	0.0136	CcSEcCtD
Methoxsalen—Herpes simplex—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.0134	CcSEcCtD
Methoxsalen—Herpes simplex—Formoterol—chronic obstructive pulmonary disease	0.000967	0.0134	CcSEcCtD
Methoxsalen—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00095	0.0134	CbGpPWpGaD
Methoxsalen—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.000919	0.0128	CcSEcCtD
Methoxsalen—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.000919	0.0128	CcSEcCtD
Methoxsalen—Herpes simplex—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.0127	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.0009	0.0127	CbGpPWpGaD
Methoxsalen—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000881	0.0124	CbGpPWpGaD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00088	0.0124	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000868	0.0122	CbGpPWpGaD
Methoxsalen—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.000867	0.012	CcSEcCtD
Methoxsalen—Leukoderma—Prednisone—chronic obstructive pulmonary disease	0.000825	0.0115	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.000819	0.0114	CcSEcCtD
Methoxsalen—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.000819	0.0114	CcSEcCtD
Methoxsalen—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000802	0.0113	CbGpPWpGaD
Methoxsalen—CYP2A13—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000791	0.0112	CbGpPWpGaD
Methoxsalen—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.000773	0.0107	CcSEcCtD
Methoxsalen—Tension—Roflumilast—chronic obstructive pulmonary disease	0.000753	0.0105	CcSEcCtD
Methoxsalen—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.000752	0.0104	CcSEcCtD
Methoxsalen—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.000745	0.0103	CcSEcCtD
Methoxsalen—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.000738	0.0102	CcSEcCtD
Methoxsalen—Dry skin—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.0102	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000713	0.0101	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.000712	0.00988	CcSEcCtD
Methoxsalen—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.000692	0.00961	CcSEcCtD
Methoxsalen—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000689	0.00957	CcSEcCtD
Methoxsalen—CYP2A6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000679	0.00958	CbGpPWpGaD
Methoxsalen—Blister—Prednisolone—chronic obstructive pulmonary disease	0.000669	0.00929	CcSEcCtD
Methoxsalen—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.000646	0.00896	CcSEcCtD
Methoxsalen—CYP2A13—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000639	0.00902	CbGpPWpGaD
Methoxsalen—CYP2A13—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000631	0.0089	CbGpPWpGaD
Methoxsalen—Infection—Roflumilast—chronic obstructive pulmonary disease	0.000622	0.00864	CcSEcCtD
Methoxsalen—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.000608	0.00845	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000598	0.00843	CbGpPWpGaD
Methoxsalen—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00823	CcSEcCtD
Methoxsalen—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00823	CcSEcCtD
Methoxsalen—CYP2A6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000568	0.00802	CbGpPWpGaD
Methoxsalen—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000566	0.00786	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.000559	0.00788	CbGpPWpGaD
Methoxsalen—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000551	0.00765	CcSEcCtD
Methoxsalen—CYP2A6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000547	0.00771	CbGpPWpGaD
Methoxsalen—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.000541	0.00751	CcSEcCtD
Methoxsalen—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.000525	0.00729	CcSEcCtD
Methoxsalen—Herpes simplex—Prednisolone—chronic obstructive pulmonary disease	0.000524	0.00727	CcSEcCtD
Methoxsalen—CYP2A13—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000518	0.00731	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000516	0.00716	CcSEcCtD
Methoxsalen—CYP1A1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000506	0.00714	CbGpPWpGaD
Methoxsalen—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000502	0.00697	CcSEcCtD
Methoxsalen—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000498	0.00691	CcSEcCtD
Methoxsalen—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.000497	0.0069	CcSEcCtD
Methoxsalen—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000495	0.00688	CcSEcCtD
Methoxsalen—CYP2A6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000494	0.00696	CbGpPWpGaD
Methoxsalen—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000483	0.00681	CbGpPWpGaD
Methoxsalen—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000479	0.00676	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000461	0.00641	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000461	0.0065	CbGpPWpGaD
Methoxsalen—CYP2A13—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000456	0.00643	CbGpPWpGaD
Methoxsalen—CYP2A13—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000451	0.00636	CbGpPWpGaD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000443	0.00624	CbGpPWpGaD
Methoxsalen—CYP1A1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.00597	CbGpPWpGaD
Methoxsalen—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000415	0.00576	CcSEcCtD
Methoxsalen—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000414	0.00575	CcSEcCtD
Methoxsalen—CYP2A6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000413	0.00582	CbGpPWpGaD
Methoxsalen—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000408	0.00576	CbGpPWpGaD
Methoxsalen—CYP1A1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.00574	CbGpPWpGaD
Methoxsalen—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.0004	0.00555	CcSEcCtD
Methoxsalen—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.0004	0.00555	CcSEcCtD
Methoxsalen—CYP2A6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000397	0.0056	CbGpPWpGaD
Methoxsalen—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000395	0.00548	CcSEcCtD
Methoxsalen—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000395	0.00548	CcSEcCtD
Methoxsalen—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000394	0.00547	CcSEcCtD
Methoxsalen—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000392	0.00545	CcSEcCtD
Methoxsalen—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000391	0.00543	CcSEcCtD
Methoxsalen—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00039	0.00542	CcSEcCtD
Methoxsalen—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00531	CcSEcCtD
Methoxsalen—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000382	0.00531	CcSEcCtD
Methoxsalen—Tension—Formoterol—chronic obstructive pulmonary disease	0.000382	0.00531	CcSEcCtD
Methoxsalen—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.00529	CcSEcCtD
Methoxsalen—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000381	0.00529	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000379	0.00534	CbGpPWpGaD
Methoxsalen—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00525	CcSEcCtD
Methoxsalen—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00525	CcSEcCtD
Methoxsalen—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000378	0.00524	CcSEcCtD
Methoxsalen—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.00524	CcSEcCtD
Methoxsalen—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.0052	CcSEcCtD
Methoxsalen—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000374	0.0052	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000374	0.00527	CbGpPWpGaD
Methoxsalen—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000372	0.00516	CcSEcCtD
Methoxsalen—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000372	0.00524	CbGpPWpGaD
Methoxsalen—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00037	0.00522	CbGpPWpGaD
Methoxsalen—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.0051	CcSEcCtD
Methoxsalen—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000367	0.00509	CcSEcCtD
Methoxsalen—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000366	0.00509	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.000364	0.00514	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000361	0.00502	CcSEcCtD
Methoxsalen—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000361	0.00502	CcSEcCtD
Methoxsalen—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000361	0.00501	CcSEcCtD
Methoxsalen—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.005	CcSEcCtD
Methoxsalen—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.00496	CcSEcCtD
Methoxsalen—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000356	0.00495	CcSEcCtD
Methoxsalen—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000354	0.00491	CcSEcCtD
Methoxsalen—CYP1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000353	0.00498	CbGpPWpGaD
Methoxsalen—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00488	CcSEcCtD
Methoxsalen—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00488	CcSEcCtD
Methoxsalen—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.00481	CcSEcCtD
Methoxsalen—CYP2A6—lung—chronic obstructive pulmonary disease	0.000344	0.0564	CbGeAlD
Methoxsalen—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000341	0.00474	CcSEcCtD
Methoxsalen—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000341	0.0558	CbGeAlD
Methoxsalen—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00034	0.00472	CcSEcCtD
Methoxsalen—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000336	0.055	CbGeAlD
Methoxsalen—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00465	CcSEcCtD
Methoxsalen—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000332	0.00461	CcSEcCtD
Methoxsalen—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.0046	CcSEcCtD
Methoxsalen—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00459	CcSEcCtD
Methoxsalen—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00033	0.00458	CcSEcCtD
Methoxsalen—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000328	0.00455	CcSEcCtD
Methoxsalen—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000328	0.00455	CcSEcCtD
Methoxsalen—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00446	CcSEcCtD
Methoxsalen—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000318	0.00441	CcSEcCtD
Methoxsalen—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000318	0.00441	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000316	0.00446	CbGpPWpGaD
Methoxsalen—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000316	0.00438	CcSEcCtD
Methoxsalen—Infection—Formoterol—chronic obstructive pulmonary disease	0.000316	0.00438	CcSEcCtD
Methoxsalen—CYP1A1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000315	0.00444	CbGpPWpGaD
Methoxsalen—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000313	0.00434	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000312	0.0044	CbGpPWpGaD
Methoxsalen—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000311	0.00432	CcSEcCtD
Methoxsalen—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00429	CcSEcCtD
Methoxsalen—Infection—Montelukast—chronic obstructive pulmonary disease	0.000309	0.00429	CcSEcCtD
Methoxsalen—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00429	CcSEcCtD
Methoxsalen—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00429	CcSEcCtD
Methoxsalen—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000308	0.00427	CcSEcCtD
Methoxsalen—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000302	0.0042	CcSEcCtD
Methoxsalen—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.0003	0.00417	CcSEcCtD
Methoxsalen—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000298	0.00414	CcSEcCtD
Methoxsalen—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000297	0.00412	CcSEcCtD
Methoxsalen—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000297	0.00412	CcSEcCtD
Methoxsalen—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000296	0.0041	CcSEcCtD
Methoxsalen—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.00405	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00029	0.0041	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00029	0.00403	CcSEcCtD
Methoxsalen—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000288	0.00399	CcSEcCtD
Methoxsalen—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000288	0.00399	CcSEcCtD
Methoxsalen—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000287	0.00404	CbGpPWpGaD
Methoxsalen—CYP2A13—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000286	0.00404	CbGpPWpGaD
Methoxsalen—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000282	0.00391	CcSEcCtD
Methoxsalen—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00028	0.00389	CcSEcCtD
Methoxsalen—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00388	CcSEcCtD
Methoxsalen—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00388	CcSEcCtD
Methoxsalen—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000279	0.00387	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000277	0.00391	CbGpPWpGaD
Methoxsalen—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000276	0.0453	CbGeAlD
Methoxsalen—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000276	0.00383	CcSEcCtD
Methoxsalen—CYP2A13—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00388	CbGpPWpGaD
Methoxsalen—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00381	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00381	CcSEcCtD
Methoxsalen—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000274	0.0038	CcSEcCtD
Methoxsalen—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00377	CcSEcCtD
Methoxsalen—CYP2A13—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000271	0.00383	CbGpPWpGaD
Methoxsalen—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00373	CcSEcCtD
Methoxsalen—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00367	CcSEcCtD
Methoxsalen—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00366	CcSEcCtD
Methoxsalen—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00365	CcSEcCtD
Methoxsalen—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00364	CcSEcCtD
Methoxsalen—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00364	CcSEcCtD
Methoxsalen—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00363	CcSEcCtD
Methoxsalen—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00026	0.00362	CcSEcCtD
Methoxsalen—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.0036	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000259	0.00365	CbGpPWpGaD
Methoxsalen—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00351	CcSEcCtD
Methoxsalen—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00351	CcSEcCtD
Methoxsalen—CYP1A1—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.000252	0.00355	CbGpPWpGaD
Methoxsalen—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00349	CcSEcCtD
Methoxsalen—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00349	CcSEcCtD
Methoxsalen—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000249	0.00351	CbGpPWpGaD
Methoxsalen—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00345	CcSEcCtD
Methoxsalen—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000248	0.0407	CbGeAlD
Methoxsalen—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00344	CcSEcCtD
Methoxsalen—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000248	0.00344	CcSEcCtD
Methoxsalen—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000247	0.00343	CcSEcCtD
Methoxsalen—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000247	0.00343	CcSEcCtD
Methoxsalen—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00343	CcSEcCtD
Methoxsalen—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000246	0.00342	CcSEcCtD
Methoxsalen—CYP1A1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000244	0.00344	CbGpPWpGaD
Methoxsalen—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.00331	CcSEcCtD
Methoxsalen—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.00329	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000236	0.00333	CbGpPWpGaD
Methoxsalen—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000234	0.00331	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00325	CcSEcCtD
Methoxsalen—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00325	CcSEcCtD
Methoxsalen—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000234	0.00325	CcSEcCtD
Methoxsalen—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00324	CcSEcCtD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000233	0.00328	CbGpPWpGaD
Methoxsalen—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000231	0.00326	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000229	0.00318	CcSEcCtD
Methoxsalen—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000227	0.0032	CbGpPWpGaD
Methoxsalen—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000225	0.00318	CbGpPWpGaD
Methoxsalen—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00312	CcSEcCtD
Methoxsalen—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00312	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—APIP—chronic obstructive pulmonary disease	0.000221	0.00312	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00307	CcSEcCtD
Methoxsalen—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00306	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00307	CbGpPWpGaD
Methoxsalen—CYP1A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00307	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00307	CbGpPWpGaD
Methoxsalen—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00306	CbGpPWpGaD
Methoxsalen—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.00301	CcSEcCtD
Methoxsalen—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00301	CbGpPWpGaD
Methoxsalen—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00295	CcSEcCtD
Methoxsalen—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000211	0.00298	CbGpPWpGaD
Methoxsalen—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000211	0.00293	CcSEcCtD
Methoxsalen—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00292	CcSEcCtD
Methoxsalen—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00292	CcSEcCtD
Methoxsalen—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.00294	CbGpPWpGaD
Methoxsalen—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00286	CcSEcCtD
Methoxsalen—CYP1A1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.00287	CbGpPWpGaD
Methoxsalen—Rash—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00278	CcSEcCtD
Methoxsalen—Rash—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00278	CcSEcCtD
Methoxsalen—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0002	0.00283	CbGpPWpGaD
Methoxsalen—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00278	CcSEcCtD
Methoxsalen—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00278	CcSEcCtD
Methoxsalen—Headache—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00276	CcSEcCtD
Methoxsalen—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00276	CcSEcCtD
Methoxsalen—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00276	CcSEcCtD
Methoxsalen—Rash—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00273	CcSEcCtD
Methoxsalen—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000196	0.00277	CbGpPWpGaD
Methoxsalen—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00272	CcSEcCtD
Methoxsalen—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00272	CcSEcCtD
Methoxsalen—Depression—Prednisone—chronic obstructive pulmonary disease	0.000196	0.00272	CcSEcCtD
Methoxsalen—Headache—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00271	CcSEcCtD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.0027	CbGpPWpGaD
Methoxsalen—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00264	CcSEcCtD
Methoxsalen—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00263	CcSEcCtD
Methoxsalen—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00263	CcSEcCtD
Methoxsalen—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00262	CcSEcCtD
Methoxsalen—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00262	CcSEcCtD
Methoxsalen—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00262	CcSEcCtD
Methoxsalen—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000189	0.00266	CbGpPWpGaD
Methoxsalen—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00261	CcSEcCtD
Methoxsalen—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00257	CcSEcCtD
Methoxsalen—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000181	0.00255	CbGpPWpGaD
Methoxsalen—CYP1A2—lung—chronic obstructive pulmonary disease	0.000181	0.0296	CbGeAlD
Methoxsalen—CYP1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00018	0.00254	CbGpPWpGaD
Methoxsalen—CYP1A1—lung—chronic obstructive pulmonary disease	0.000178	0.0292	CbGeAlD
Methoxsalen—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00248	CcSEcCtD
Methoxsalen—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.00246	CcSEcCtD
Methoxsalen—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00248	CbGpPWpGaD
Methoxsalen—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000174	0.00245	CbGpPWpGaD
Methoxsalen—CYP1A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00245	CbGpPWpGaD
Methoxsalen—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000172	0.00239	CcSEcCtD
Methoxsalen—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000171	0.00242	CbGpPWpGaD
Methoxsalen—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00239	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000165	0.00233	CbGpPWpGaD
Methoxsalen—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000165	0.00232	CbGpPWpGaD
Methoxsalen—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00218	CcSEcCtD
Methoxsalen—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00216	CcSEcCtD
Methoxsalen—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000155	0.00219	CbGpPWpGaD
Methoxsalen—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000153	0.00213	CcSEcCtD
Methoxsalen—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000151	0.00214	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000151	0.00213	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000147	0.00207	CbGpPWpGaD
Methoxsalen—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00206	CbGpPWpGaD
Methoxsalen—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000146	0.00205	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GC—chronic obstructive pulmonary disease	0.000143	0.00201	CbGpPWpGaD
Methoxsalen—CYP1A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00201	CbGpPWpGaD
Methoxsalen—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00197	CcSEcCtD
Methoxsalen—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00197	CcSEcCtD
Methoxsalen—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.00196	CbGpPWpGaD
Methoxsalen—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00192	CcSEcCtD
Methoxsalen—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000138	0.00194	CbGpPWpGaD
Methoxsalen—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00191	CcSEcCtD
Methoxsalen—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.0019	CcSEcCtD
Methoxsalen—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000136	0.00192	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000133	0.00187	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000131	0.00184	CbGpPWpGaD
Methoxsalen—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000129	0.00179	CcSEcCtD
Methoxsalen—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000128	0.00181	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.00176	CcSEcCtD
Methoxsalen—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00174	CcSEcCtD
Methoxsalen—Infection—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00173	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000122	0.00172	CbGpPWpGaD
Methoxsalen—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00169	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000121	0.0017	CbGpPWpGaD
Methoxsalen—CYP1A1—PPARA activates gene expression—CTGF—chronic obstructive pulmonary disease	0.000117	0.00166	CbGpPWpGaD
Methoxsalen—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—chronic obstructive pulmonary disease	0.000115	0.00162	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000115	0.00162	CbGpPWpGaD
Methoxsalen—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00158	CcSEcCtD
Methoxsalen—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00157	CcSEcCtD
Methoxsalen—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00153	CcSEcCtD
Methoxsalen—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00151	CcSEcCtD
Methoxsalen—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00151	CcSEcCtD
Methoxsalen—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.0015	CcSEcCtD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.00151	CbGpPWpGaD
Methoxsalen—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000103	0.00143	CcSEcCtD
Methoxsalen—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00142	CcSEcCtD
Methoxsalen—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000102	0.00143	CbGpPWpGaD
Methoxsalen—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00142	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00142	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.00142	CbGpPWpGaD
Methoxsalen—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.00138	CcSEcCtD
Methoxsalen—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	9.93e-05	0.0014	CbGpPWpGaD
Methoxsalen—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.00137	CcSEcCtD
Methoxsalen—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	9.81e-05	0.00138	CbGpPWpGaD
Methoxsalen—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	9.79e-05	0.00138	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	9.66e-05	0.00136	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	9.53e-05	0.00134	CbGpPWpGaD
Methoxsalen—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	9.42e-05	0.00133	CbGpPWpGaD
Methoxsalen—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.22e-05	0.00128	CcSEcCtD
Methoxsalen—CYP1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.11e-05	0.00129	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9e-05	0.00127	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	8.88e-05	0.00125	CbGpPWpGaD
Methoxsalen—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.00123	CcSEcCtD
Methoxsalen—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	8.85e-05	0.00125	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	8.74e-05	0.00123	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	8.65e-05	0.00122	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	8.54e-05	0.0012	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.47e-05	0.0012	CbGpPWpGaD
Methoxsalen—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.27e-05	0.00115	CcSEcCtD
Methoxsalen—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	8.14e-05	0.00115	CbGpPWpGaD
Methoxsalen—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.04e-05	0.00113	CbGpPWpGaD
Methoxsalen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	7.92e-05	0.00112	CbGpPWpGaD
Methoxsalen—Rash—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.00109	CcSEcCtD
Methoxsalen—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.00109	CcSEcCtD
Methoxsalen—Headache—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.00109	CcSEcCtD
Methoxsalen—CYP2A13—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.79e-05	0.0011	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.79e-05	0.0011	CbGpPWpGaD
Methoxsalen—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	7.77e-05	0.0011	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GCLC—chronic obstructive pulmonary disease	7.71e-05	0.00109	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.57e-05	0.00107	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.47e-05	0.00105	CbGpPWpGaD
Methoxsalen—Nausea—Prednisone—chronic obstructive pulmonary disease	7.43e-05	0.00103	CcSEcCtD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.4e-05	0.00104	CbGpPWpGaD
Methoxsalen—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.38e-05	0.00104	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CTGF—chronic obstructive pulmonary disease	7.03e-05	0.000992	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	7.01e-05	0.000989	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	6.88e-05	0.000971	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	6.79e-05	0.000958	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.66e-05	0.00094	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	6.66e-05	0.00094	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	6.6e-05	0.000931	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.48e-05	0.000914	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.4e-05	0.000903	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.34e-05	0.000895	CbGpPWpGaD
Methoxsalen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.34e-05	0.000895	CbGpPWpGaD
Methoxsalen—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	6.32e-05	0.000892	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.31e-05	0.000891	CbGpPWpGaD
Methoxsalen—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	6.29e-05	0.000887	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.23e-05	0.000878	CbGpPWpGaD
Methoxsalen—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	6.2e-05	0.000875	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	5.94e-05	0.000838	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.81e-05	0.000819	CbGpPWpGaD
Methoxsalen—CYP1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.8e-05	0.000819	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.74e-05	0.00081	CbGpPWpGaD
Methoxsalen—CYP1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.72e-05	0.000807	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	5.57e-05	0.000786	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.4e-05	0.000762	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.33e-05	0.000752	CbGpPWpGaD
Methoxsalen—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.1e-05	0.000719	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.97e-05	0.0007	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	4.72e-05	0.000666	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.71e-05	0.000664	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.48e-05	0.000632	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.43e-05	0.000625	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.43e-05	0.000624	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.000611	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.000599	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.000599	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.08e-05	0.000576	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	4.04e-05	0.000571	CbGpPWpGaD
Methoxsalen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	4.04e-05	0.000571	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.03e-05	0.000568	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.97e-05	0.00056	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.93e-05	0.000555	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	3.83e-05	0.00054	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.73e-05	0.000526	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.7e-05	0.000522	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.67e-05	0.000518	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.000515	CbGpPWpGaD
Methoxsalen—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.62e-05	0.000511	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.56e-05	0.000502	CbGpPWpGaD
Methoxsalen—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.51e-05	0.000495	CbGpPWpGaD
Methoxsalen—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000488	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—ALB—chronic obstructive pulmonary disease	3.2e-05	0.000451	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.16e-05	0.000445	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.11e-05	0.000438	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.06e-05	0.000432	CbGpPWpGaD
Methoxsalen—CYP2A13—Metabolism—NOS3—chronic obstructive pulmonary disease	3.06e-05	0.000432	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.93e-05	0.000414	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.91e-05	0.00041	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.86e-05	0.000403	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.85e-05	0.000402	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.82e-05	0.000398	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000397	CbGpPWpGaD
Methoxsalen—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.71e-05	0.000382	CbGpPWpGaD
Methoxsalen—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.000377	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.65e-05	0.000374	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.18e-05	0.000307	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.09e-05	0.000295	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.07e-05	0.000292	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.01e-05	0.000284	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.89e-05	0.000266	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.87e-05	0.000264	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.82e-05	0.000256	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.74e-05	0.000245	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.69e-05	0.000238	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.56e-05	0.00022	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.54e-05	0.000217	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.45e-05	0.000204	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.44e-05	0.000203	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.44e-05	0.000203	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.43e-05	0.000202	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.41e-05	0.000198	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.4e-05	0.000198	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.35e-05	0.00019	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.33e-05	0.000188	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.3e-05	0.000184	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.29e-05	0.000183	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.26e-05	0.000178	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.08e-05	0.000152	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.06e-05	0.00015	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.93e-06	0.00014	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.92e-06	0.00014	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.82e-06	0.000139	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.16e-06	0.000129	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.96e-06	0.000126	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	8.58e-06	0.000121	CbGpPWpGaD
Methoxsalen—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.21e-06	0.000116	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.67e-06	0.000108	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.58e-06	0.000107	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.92e-06	9.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.89e-06	9.71e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.79e-06	9.58e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	6.39e-06	9.02e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.37e-06	8.99e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.33e-06	8.93e-05	CbGpPWpGaD
Methoxsalen—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.12e-06	8.63e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6e-06	8.46e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.31e-06	7.5e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.24e-06	7.39e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.88e-06	6.89e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.63e-06	6.53e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.08e-06	5.75e-05	CbGpPWpGaD
Methoxsalen—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.9e-06	5.5e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.15e-06	4.44e-05	CbGpPWpGaD
Methoxsalen—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.01e-06	4.25e-05	CbGpPWpGaD
